Loading...
Loading...
Bodhi Tree Biotechnology Inc
Bodhi Tree Biotechnology Inc. Spoken Alpha tracks BDTB's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks BDTB's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BDTB.
curl https://api.spokenalpha.com/v1/companies/BDTB| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.34 | $2.35 | +42.0% | +2.4% | 0.0% |
| Q4 FY2026 | $3.22 | $2.28 | +41.1% | +1.8% | +0.3% |
| Q3 FY2026 | $3.72 | $2.54 | +46.3% | +2.5% | +1.6% |
| Q2 FY2026 | $3.24 | $2.33 | +39.1% | -5.4% | -5.8% |
| Q1 FY2025 | $3.44 | $2.48 | +38.6% | -1.6% | +0.5% |
| Q4 FY2025 | $3.69 | $2.63 | +40.3% | -0.7% | -0.2% |
| Q3 FY2025 | $3.81 | $2.61 | +45.8% | +5.1% | +3.2% |
| Q2 FY2025 | $3.84 | $2.59 | +48.1% | -4.9% | -2.7% |
| Q1 FY2024 | $3.48 | $2.52 | +38.1% | -2.6% | -4.4% |
| Q4 FY2024 | $3.53 | $2.48 | +42.5% | -1.4% | +0.3% |